Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Collagen-targeted MRI contrast agent for molecular imaging of fibrosis.
Caravan P, Das B, Dumas S, Epstein FH, Helm PA, Jacques V, Koerner S, Kolodziej A, Shen L, Sun WC, Zhang Z. Caravan P, et al. Among authors: koerner s. Angew Chem Int Ed Engl. 2007;46(43):8171-3. doi: 10.1002/anie.200700700. Angew Chem Int Ed Engl. 2007. PMID: 17893943 No abstract available.
A lysine walk to high relaxivity collagen-targeted MRI contrast agents.
Caravan P, Das B, Deng Q, Dumas S, Jacques V, Koerner SK, Kolodziej A, Looby RJ, Sun WC, Zhang Z. Caravan P, et al. Among authors: koerner sk. Chem Commun (Camb). 2009 Jan 28;(4):430-2. doi: 10.1039/b819098d. Epub 2008 Dec 10. Chem Commun (Camb). 2009. PMID: 19137175
Topical Application of a Mast Cell Stabilizer Improves Impaired Diabetic Wound Healing.
Tellechea A, Bai S, Dangwal S, Theocharidis G, Nagai M, Koerner S, Cheong JE, Bhasin S, Shih TY, Zheng Y, Zhao W, Zhang C, Li X, Kounas K, Panagiotidou S, Theoharides T, Mooney D, Bhasin M, Sun L, Veves A. Tellechea A, et al. Among authors: koerner s. J Invest Dermatol. 2020 Apr;140(4):901-911.e11. doi: 10.1016/j.jid.2019.08.449. Epub 2019 Sep 27. J Invest Dermatol. 2020. PMID: 31568772 Free article.
Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists.
Chen J, Haller CA, Jernigan FE, Koerner SK, Wong DJ, Wang Y, Cheong JE, Kosaraju R, Kwan J, Park DD, Thomas B, Bhasin S, De La Rosa RC, Premji AM, Liu L, Park E, Moss AC, Emili A, Bhasin M, Sun L, Chaikof EL. Chen J, et al. Among authors: koerner sk. Sci Adv. 2020 Jan 15;6(3):eaay8230. doi: 10.1126/sciadv.aay8230. eCollection 2020 Jan. Sci Adv. 2020. PMID: 31998845 Free PMC article.
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.
Lapierre JM, Eathiraj S, Vensel D, Liu Y, Bull CO, Cornell-Kennon S, Iimura S, Kelleher EW, Kizer DE, Koerner S, Makhija S, Matsuda A, Moussa M, Namdev N, Savage RE, Szwaya J, Volckova E, Westlund N, Wu H, Schwartz B. Lapierre JM, et al. Among authors: koerner s. J Med Chem. 2016 Jul 14;59(13):6455-69. doi: 10.1021/acs.jmedchem.6b00619. Epub 2016 Jun 29. J Med Chem. 2016. PMID: 27305487
174 results